SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-710986
Filing Date
2016-09-15
Accepted
2016-09-15 16:08:01
Documents
70
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d237696d10q.htm 10-Q 754590
2 EX-10.11 d237696dex1011.htm EX-10.11 14389
3 EX-31.1 d237696dex311.htm EX-31.1 8530
4 EX-31.2 d237696dex312.htm EX-31.2 8523
5 EX-32.1 d237696dex321.htm EX-32.1 4873
12 GRAPHIC g237696666.jpg GRAPHIC 3654
13 GRAPHIC g237696855.jpg GRAPHIC 47238
14 GRAPHIC g237696g31k03.jpg GRAPHIC 2319
15 GRAPHIC g237696g74q59.jpg GRAPHIC 49889
  Complete submission text file 0001193125-16-710986.txt   4186009

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ptgx-20160630.xml EX-101.INS 671958
7 XBRL TAXONOMY EXTENSION SCHEMA ptgx-20160630.xsd EX-101.SCH 51876
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ptgx-20160630_cal.xml EX-101.CAL 54566
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ptgx-20160630_def.xml EX-101.DEF 195988
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ptgx-20160630_lab.xml EX-101.LAB 383595
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ptgx-20160630_pre.xml EX-101.PRE 301884
Mailing Address 521 COTTONWOOD DRIVE, SUITE 100 MALPITAS CA 95035-7404
Business Address 521 COTTONWOOD DRIVE, SUITE 100 MALPITAS CA 95035-7404 408-649-7370
Protagonist Therapeutics, Inc (Filer) CIK: 0001377121 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37852 | Film No.: 161887272
SIC: 2834 Pharmaceutical Preparations